Purpose of review Sodium/hydrogen exchangers (NHEs) are a large family of transport proteins catalyzing the exchange of cations for protons across lipid bilayer membranes. Several isoforms are expressed in b cells of the endocrine pancreas, including the recently discovered and poorly characterized isoform NHA2. This review will summarize advances in our understanding of the roles of NHEs in the regulation of insulin secretion in b cells.
INTRODUCTION
Sodium/hydrogen exchangers (NHEs) are membrane transport proteins catalyzing the exchange of cations with protons (antiporters) [1] [2] . In mammals, 13 evolutionary conserved NHE isoforms, encoded by the SLC9 (solute carrier classification of transporters) gene family, are currently known [3 & ]. SLC9 transporters are divided into three subgroups [4] . The SLC9A subgroup encompasses plasmalemmal isoforms NHE1-5 (SLC9A1-5) and intracellular isoforms NHE6-9 (SLC9A6-9). The SLC9B subgroup consists of two recently cloned isoforms, NHA1 and NHA2 (SLC9B1 and SLC9B2, respectively). The latter are also known as NHEDC1 and NHEDC2. The SLC9C subgroup consists of a sperm-specific NHE (SLC9C1) and a putative NHE (SLC9C2). Each NHE isoform possesses unique structural features that dictate its functional role, mode of regulation and cellular as well as subcellular distribution. NHEs participate in a wide variety of physiological processes including cytosolic and organellar pH homeostasis, transepithelial salt transport and both systemic and single cell volume regulation.
As shown in Fig. 1 , eight NHE isoforms can be found in murine islets of the endocrine pancreas on mRNA level. Of these, two are plasmalemmal (NHE1, NHE5) and six are intracellular (NHA1, NHA2, NHE6, 7, 8 and 9). To the best of our knowledge, only the ubiquitous isoform NHE1 and the recently cloned isoform NHA2 have been thoroughly studied in b cells [5 && ,6,7] .
MOLECULAR MECHANISMS OF INSULIN SECRETION BY b CELLS
Insulin secretion by b cells is tightly coupled to circulating glucose levels. Plasmalemmal glucose transporters of the SLC2 transporter family ensure efficient uptake of extracellular glucose into b cells and thereby initiation of the insulin secretion cascade [8] . After uptake, glucose metabolism results in an increase of the cellular ATP/ADP ratio leading to closure of ATP-sensitive potassium (K ATP ) channels, the main determinants of the b cell membrane potential. In addition to glucose, K ATP channel closure can also be attained pharmacologically by sulfonylureas, which target the SUR1 K ATP channel regulatory subunit [9] . Membrane depolarization evoked by K ATP channel closure directly activates voltage-sensitive L-type Ca þþ channels. The ensuing rise of intracellular Ca þþ then drives the exocytosis of insulin-containing large dense core vesicles (LDCVs) [10] . Concurrently, glucose metabolism elicits signals that augment insulin secretion independent of K ATP channels and intracellular Ca þþ [11] . K ATP channel-dependent and channelindependent pathways are referred to as the triggering and amplifying pathways, respectively [12] . Although there is general consensus on the basic molecular mechanisms underlying the K ATP channel-dependent pathway, as outlined above, the K ATP channel-independent pathways are still incompletely understood [13] .
ROLE OF SODIUM/HYDROGEN EXCHANGER 1 IN b CELLS
High glucose increases the cytoplasmic pH of primary b cells and b-cell lines [14] [15] [16] . The underlying mechanisms of this phenomenon and its role in insulin secretion, however, have been a matter of controversy. Juntti-Berggren et al. [17] reported that the glucose-induced alkalinization was dependent on extracellular Na þ , sensitive to inhibition by the NHE inhibitor ethylisopropylamiloride (EIPA) and thus likely the result of plasmalemmal NHE activity.
Based on their studies in murine islets, Lindstrom et al. [14] proposed that glucose-induced alkalinization serves as a direct stimulus of insulin secretion. Other studies, however, reported the contrary in that intracellular alkalinization inhibited insulin secretion [18] and acidification or inhibition of NHE transport stimulated it [19] [20] .
To address these questions, Stiernet et al. investigated NHE1 swe/swe mutant mice, which bear a spontaneous premature stop codon within the coding region of the SLC9A1 gene and thus lack a functional plasmalemmal NHE1 protein [6, 21] . Upon intracellular acidification in the absence of HCO 3 -/CO 2 , virtually no re-alkalinization in mutant b cells occurred compared with wild-type cells, indicating that NHE1 is the only NHE present at the cell surface in murine b cells activated at low intracellular pH. Under physiological HCO 3 -/CO 2 -containing conditions, however, basal intracellular pH as well as the alkalinization produced by high glucose was clearly independent of NHE1 and involved HCO 3 -dependent mechanisms instead. Moreover, all effects of glucose on intracellular Ca þþ and on the triggering and amplifying pathways of insulin secretion were independent of NHE1, demonstrating that NHE1 has no role in stimulus-secretion coupling. Interestingly, in the presence of HCO 3 -/CO 2 , the NHE inhibitors EIPA and dimethylamiloride (DMA), but not the more selective NHE1 inhibitor cariporide, stimulated insulin secretion in both NHE1 wild-type and mutant islets without affecting the intracellular pH [6] . These findings suggested unspecific, NHE1-independent effects of EIPA and DMA in islets, possibly involving KEY POINTS NHA2 plays an important role in clathrin-mediated endocytosis and insulin secretion in b cells. NHE1 defends b cells from intracellular acidification but is not involved in glucose-induced alkalinization of the b cell or insulin secretion.
Several additional NHE isoforms are expressed in b cells, but their physiological role remains currently unknown. inhibition of another amiloride-sensitive NHE or direct inhibition of K ATP channels [22, 23] .
In addition to full-length plasmalemmal NHE1, b cells were found to express a shorter splice variant of NHE1 that localizes specifically to insulincontaining LDCVs [7] . Although full-length NHE1 protein ($100 kDa) was absent from islets in NHE1 swe/swe mutant mice, the shorter splice variant ($65 kDa) was still present. The function of this NHE1 splice variant in islets has not been studied.
ROLE OF NHA2 IN b CELLS
Based on chromosomal localization of the NHA2 gene, tissue distribution, transport characteristics and inhibitor sensitivity, NHA2 was proposed to be the long-sought sodium/lithium countertransporter [24] . Sodium/lithium countertransport is a highly heritable trait that was linked to the development of essential hypertension and diabetes in humans [25] [26] [27] [28] . In line with these studies and a potential role in insulin secretion, NHA2 mRNA and protein are expressed in rodent b-cell lines [5 && ,24,29] , as well as in murine and human primary b cells [5 && ]. Our subcellular fractionation and imaging studies indicate that NHA2 resides in transferrinpositive endosomes and synaptic-like microvesicles (SLMVs), but not in insulin-containing LDCVs in b cells. To search for a putative role of NHA2 in insulin secretion in vivo, we generated two different strains of NHA2 knock-out mice [5 && ]. Both strains of NHA2 knock-out mice exhibited a pathological glucose tolerance with diminished insulin secretion but normal peripheral insulin sensitivity when subjected to intraperitoneal glucose and insulin tolerance tests, respectively. Interestingly, even heterozygous mice were not normal and had an impaired glucose tolerance. In-vitro studies with islets isolated from NHA2 knock-out or heterozygous mice confirmed an insulin secretion deficit upon stimulation with glucose or the sulfonylurea tolbutamide. Insulin secretion, however, was not affected when the b cells were depolarized directly by addition of supraphysiological (50 mmol/l) extracellular K þ . Similar results were obtained when NHA2 was knocked down in the murine b cell line Min6. The observed insulin secretion deficit could be rescued by overexpression of wild-type but not functionally dead human NHA2 in NHA2-deficient Min6 cells, indicating that NHA2 transport is required. Surprisingly, although NHA2 also localizes to SLMVs in b cells, glucoseinduced gamma aminobutyric acid (GABA) secretion was not affected by loss of NHA2.
The functional observation that insulin secretion was unaltered by direct K þ -mediated b-cell depolarization but reduced with glucose and sulfonylurea stimulation indicated that the defect induced by the loss of NHA2 was between K ATP channel closure and the final exocytotic event. This suggested disturbed intracellular Ca þþ homeostasis as a likely cause. Measurements of cytosolic Ca þþ in b cells of intact islets, however, demonstrated that loss of NHA2 had no impact on intracellular Ca þþ levels, indicating that the NHA2 effect observed with secretagogues and sulfonylureas was downstream of K ATP channels and Ca þþ signaling in islets.
It is well known that K þ -induced insulin secretion from islets is far less sustained than with sulfonylurea or glucose stimulation and induces primarily the release of a special pool of predocked vesicles at the plasma membrane [30, 31] . Thus, endosomal NHA2 function may not be required during the release of predocked vesicles. To study this in more detail, we performed the following experiment: islets were first incubated in high-glucose medium to partially deplete the granule pool, then subjected to a 15-min low-glucose resting phase and finally depolarized by addition of extracellular K þ . With this protocol, insulin secretion was $50% reduced in NHA2 knock-out islets compared with wild-type islets, which is similar in magnitude to the reduction we observed when we stimulated knock-out islets with secretatogues or sulfonylureas. The result of this experiment revealed that direct depolarization-induced insulin secretion is not universally conserved in NHA2 knock-out islets. This observation would fit with the hypothesis that direct K þ -mediated depolarization preferentially induces a non-sustained release of predocked vesicles and that only under conditions of continued insulin secretion is NHA2 action required. Alternatively, in the absence of physiological secretagogues, high K þ may directly stimulate NHA2-independent pathways of insulin secretion that compensate for the loss of NHA2.
Given its endosomal localization and the intriguing observations outlined above, we reasoned that NHA2 may primarily affect endocytosis in b cells with an indirect impact on LDCV exocytosis. Previous reports demonstrated that endocytosis and exocytosis are tightly coupled in b cells with inhibition of endocytosis resulting in decreased insulin secretion [32] [33] [34] . Our experiments performed with Min6 or primary b cells revealed a reduction of clathrin-dependent, but not clathrin-independent, endocytosis upon loss of NHA2, suggesting that defective endo-exocytosis coupling may be the mechanism for the secretory deficit observed. But what is the function of NHA2 in endosomes and SLMVs in the b cell? Our data indicate that loss of NHA2 has no impact on endosomal steady-state pH and does not affect GABA secretion in b cells. Thus, the role of NHA2 in the endosome may not be regulation of pH but control of endosomal Na þ concentration. It is also possible that NHA2 is only present in a subset of specialized endocytotic vesicles and therefore escaped our endosomal pH measurements. In the case of SLMVs, which can bud either directly from the plasma membrane or from endosomal intermediates, the direct plasma membrane-related biogenesis pathway avoiding endosomal intermediates may explain the fact that we could not detect differences in GABA secretion between wild-type and knock-out islets [35, 36] . Thus, although our data clearly indicate a critical role of the NHE NHA2 for clathrin-mediated endocytosis and insulin secretion in b cells, many fundamental questions remain unanswered at the moment. Given the peculiar phenotype of NHA2 knock-out mice, future work should also address the potential involvement of NHA2 in the pathogenesis of b-cell disorders in humans. Interestingly, several single-nucleotide polymorphisms (SNPs) affecting the transport function of human NHA2 were recently described [37] . Whether human subjects carrying functionally relevant SNPs have defective insulin secretion has not been studied.
WHAT ABOUT OTHER SODIUM/ HYDROGEN EXCHANGERS IN ISLET CELLS?
Our data indicate significant expression of intracellular NHEs 6-9 in islets on mRNA level (Fig. 1) . Although b cells account for the large majority of islet cells, it is still possible that these data reflect NHE expression by non-b cells. Publicly available microarray data (http://www.t1dbase.org), however, indicate that NHEs 6-9 are indeed present in primary rodent b cells. Interestingly, in the same database, NHEs 6-9 are also reported to be expressed in human islets.
NHE7 localizes to the trans-Golgi network and is insensitive to inhibition by amiloride [38, 39] . The physiological function of NHE7 is not known and the phenotype of a knock-out mouse has not been reported. Given the residence in the Golgi, NHE7 may have a role in insulin synthesis or maturation. NHE8 is present at the plasma membrane of epithelial cells in the kidney and intestine, whereby in HeLa and COS7 cells it was found to localize to the mid-Golgi and trans-Golgi [38, [40] [41] [42] . In contrast to NHE7, NHE8 is amiloride and EIPA-sensitive [43] . As plasmalemmal NHE transport is absent in NHE1deficient islets, it seems unlikely that functionally active NHE8 is present at the plasma membrane of b cells [6] . Instead, NHE8 may localize to the Golgi in b cells, as reported in HeLa and COS7 cells, and affect synthesis or maturation of insulin. The differential effects of DMA and EIPA (stimulation of insulin secretion) versus cariporide (no effect on insulin secretion) in islets described earlier could theoretically be caused by inhibition of NHE8 [6] . NHE8 knock-out mice have been generated recently and could be employed to address these questions [44, 45] . NHEs 6 and 9 are endosomal NHEs and thus localize to the same organelle as NHA2 [38] . In contrast to NHA2, NHE6 and NHE9 also transport K þ in addition to Na þ . Experimental evidence indicates that NHE6 and NHE9 function as K þ /H þ exchangers in endosomes, counteracting endosomal acidification by the V-ATPase [38, 46] . As is the case for NHA2 in b cells, NHE6 and NHE9 were shown to be involved in clathrin-mediated endocytosis in nonislets cells [46, 47] . Thus, it is tempting to speculate that NHE6 and NHE9 also participate in endo-exocytosis coupling in b cells and therefore have a role in insulin secretion. Clearly, given the phenotype of NHA2 knock-out mice, there is no redundance with NHE6 or NHE9, or both, compensating for the loss of NHA2 in islets. Future investigations of mice lacking one or several endosomal NHE isoforms should shed light on the functional interactions between NHA2, NHE6 and NHE9 in islets. Moreover, the study of patients with mutations in NHE6 or NHE9 will allow the determination of whether these NHEs have a role in insulin secretion in humans in vivo.
CONCLUSION
NHE1 defends b cells from intracellular acidification, but has no role in stimulus-secretion coupling. The function of a short NHE1 splice-variant expressed exclusively in insulin-containing LDCVs is not known.
Recent data indicate a critical role of NHA2 for clathrin-mediated endocytosis and insulin secretion in b cells in vitro and in vivo. The exact function of NHA2 in b cell endosomes and SLMVs, as well as the relationship to insulin secretion, remain currently unknown and warrant further study. Given the peculiar phenotype of NHA2 knock-out mice, future work should also address the potential involvement of NHA2 in the pathogenesis of b-cell disorders in humans. In addition to NHE1 and NHA2, islet cells express significant amounts of the intracellular NHE isoforms 6, 7, 8 and 9, but their role in insulin secretion has not been explored thus far.
